AI healthcare buzz lifts the Hang Seng Index; Hsi Esg Enhanced Select Index Etf (03136.HK) surges more than 1.5%.
NewTimeSpace, 13 Jan – AI-healthcare and tech-heavyweights ignited Hong Kong, pushing the Hang Seng Index 2 % higher by late morning. At 11:12 a.m. the Hsi Esg Enhanced Select Index Etf (03136.HK) was up more than 1.5 % intraday.
Listed data show 03136.HK – launched by Hang Seng Investment Management – is the first local ETF directly tracking the Hang Seng ESG 50 Index. Marketed as “one-click access to Hong Kong’s ESG high-flyers”, it blends sustainability screens with core-equity exposure.
The benchmark holds 50 locally listed leaders screened for ESG scores and excludes controversial sectors. Heavyweights range from dividend-rich HSBC, AIA and HKEX to new-economy names such as WuXi Biologics and Sunny Optical, giving the basket an “old-economy stability plus new-economy momentum” balance.
NewTimeSpace Research adds that Hang Seng Tech is now primed for a “Davies triple-play” of upward earnings revisions, valuation re-rating and returning south-bound flows, leaving AI-application names with high risk-adjusted odds over the medium term. HK high-dividend stocks retain a tax-exempt edge for onshore insurers, keeping them ahead of their A-share peers. The innovation-drug complex is gaining twin leverage from narrowing China-U.S. price gaps, while the new-consumption segment looks poised to replay the 2019-21 core-asset bull market as policy tailwinds and traffic-driven monetisation spark re-rating.
- Liquor Sales Heat Up Ahead of Spring Festival! E Fund CSI Liquor Index ETF (03189.HK) Rises Over 1% Against Market Trend
- AI Boom Drives Google to Record $400B Revenue; Samsung Bloomberg Global Semiconductor Etf (03132.HK) Surges Nearly 3% in Afternoon Trade
- Surging! South Korea's KOSPI Index Up Over 28% YTD, Xtrackers MSCI Korea UCITS ETF (02848.HK) Drops Nearly 7% in Half-Day Trading
- NewTimeSpace | IPO Decoding: Vitalink Technology – The Nano Artist Tied to Apple’s Supply Chain, High Growth Hides Imbalance Risks
- Expectations Realized! Hong Kong Healthcare Sustains Recovery, CSOP Hang Seng Biotech ETF (03174.HK) Surges Over 3.5% Intraday